Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke

Study Title:Early Neurovascular Decoupling Trajectories after Revascularization in Acute Ischemic Stroke using Multimodal Monitoring（MAP-END）

1. Background: Despite successful revascularization with endovascular thrombectomy (EVT) for acute ischemic stroke (AIS), significant heterogeneity persists in patients' functional recovery. The underlying physiological mechanisms of this variability remain poorly understood, limiting accurate prognosis and the development of personalized rehabilitation strategies. Neurovascular coupling (NVC), the precise physiological link between neural activity and regional cerebral blood flow, is fundamental for normal brain function. Post-stroke, factors such as ischemia-reperfusion injury and neuroinflammation may lead to NVC dysfunction, i.e., neurovascular decoupling. This decoupling is hypothesized to be a critical bridge connecting the primary ischemic insult to secondary neurological dysfunction and poor recovery. Currently, the dynamic evolution of early neurovascular decoupling (particularly in the hyper-acute to sub-acute phases) following successful thrombectomy in AIS patients is not well characterized. Furthermore, whether such dynamic trajectories are systematically associated with distinct long-term functional recovery phenotypes lacks evidence from multimodal physiological monitoring. This study hypothesizes that quantifiable, heterogeneous trajectories of neurovascular decoupling exist in the early post-thrombectomy period and that these distinct trajectory patterns can predict patients' 90-day functional outcomes.
2. Objectives: 2.1.Primary Objective: To delineate and quantify the trajectories of early neurovascular decoupling (within Days 1-3 and at Day 7) in AIS patients following successful endovascular thrombectomy. 2.2.Secondary Objectives: To investigate the association between early neurovascular decoupling trajectories (based on TCD, EEG, and F-wave parameters) and patients' 90-day functional outcome (modified Rankin Scale, mRS). To explore differences in clinical characteristics, infarct volume, and collateral circulation among subgroups defined by different neurovascular decoupling trajectories.
3. Study Design: A prospective, single-center, observational cohort study.
4. Study Population: 4.1.Target Population: Adult patients with AIS due to anterior circulation large vessel occlusion who successfully undergo endovascular thrombectomy (mTICI grade 2b-3) within 24 hours of symptom onset. 4.2.Sample Size: This is an exploratory study. We plan to consecutively enroll all eligible patients over a 24-month period, with a target sample size of approximately 180 participants.
5. Methods: 5.1.Data Collection Time Points: All research-related assessments will be conducted at the following fixed time points: T1 (Baseline/Early Phase): Within 24-72 hours post-thrombectomy. T2 (Sub-acute Phase): At Day 7 (±1 day) post-thrombectomy. T3 (Long-term Outcome): At Day 90 (±7 days) post-thrombectomy. 5.2.Assessments and Tools: A. Multimodal Physiological Monitoring - Performed at T1 and T2. Transcranial Doppler (TCD): Purpose: To assess cerebral hemodynamic status. Parameters: Peak systolic velocity (PSV), end-diastolic velocity (EDV), mean flow velocity (MFV), and pulsatility index (PI) will be measured in bilateral middle cerebral arteries (MCA). The affected-to-unaffected side ratios will be calculated. Electroencephalography (EEG): Purpose: To assess cortical neuroelectrical activity. Method: Resting-state EEG recordings for at least 30 minutes using the standard 10-20 system. Analysis Parameters: Relative power spectral density (δ, θ, α, β bands), brain symmetry indices (e.g., alpha-delta power ratio symmetry), and functional connectivity metrics within specific frequency bands. F-wave Studies: Purpose: To assess spinal anterior horn motoneuron excitability. Method: Stimulation of the median or ulnar nerve on the affected side (and the unaffected side if feasible). Parameters: F-wave persistence, minimal latency, mean latency, and F-wave amplitude/M-wave amplitude ratio.
6. Clinical Assessments Neurological Deficit: Assessed using the National Institutes of Health Stroke Scale (NIHSS) at T1, T2, and T3. Functional Outcome: Assessed at T3 via face-to-face interview or standardized telephone interview using the modified Rankin Scale (mRS). The primary analysis will dichotomize the mRS into favorable outcome (mRS 0-2) and unfavorable outcome (mRS 3-6).
7. Imaging Data - Collected from clinical records. Baseline Imaging: Stroke etiology (TOAST classification), assessment of infarct core and penumbra (based on CTP or MRI-DWI/PWI). Post-thrombectomy Imaging: Final infarct volume (measured on DWI or FLAIR sequences 24-48 hours post-procedure), mTICI grade. Vascular Imaging: Collateral circulation grading (based on CTA). 5.3.Key Variables and Definitions Neurovascular Decoupling Trajectory: Will be identified by applying longitudinal data analysis models (e.g., Group-Based Trajectory Modeling) to the composite index derived from TCD mean flow velocity of the middle cerebral artery, EEG power in the C3/C4 electrodes, and F-wave persistence across T1 and T2 time points.
8. Statistical Analysis Plan 6.1.Descriptive Statistics: Baseline demographic, clinical, and imaging characteristics will be reported. 6.2.Trajectory Modeling: Group-Based Trajectory Modeling (GBTM) or Latent Class Growth Analysis (LCGA) will be used to identify distinct patterns of longitudinal change trajectories in neurovascular parameters from T1 to T2. 6.3.Association Analysis: Multivariable logistic regression models, adjusted for known prognostic factors (e.g., age, baseline NIHSS, infarct volume, mTICI grade), will be used to test whether membership in a specific identified "neurovascular decoupling trajectory" pattern is independently associated with 90-day favorable/unfunctional outcome. 6.4.Predictive Performance: The area under the receiver operating characteristic curve (AUC) of a predictive model combining clinical variables and specific neurovascular trajectory patterns will be calculated and compared against a baseline model containing clinical variables only. 6.5.Subgroup Analysis: Baseline characteristics will be compared among the defined trajectory patterns. 6.6.Significance Level: A two-sided p-value < 0.05 will be considered statistically significant. Appropriate corrections for multiple comparisons (e.g., Bonferroni) will be applied.
9. Ethical and Regulatory Considerations The study protocol has been reviewed and approved by the Ethics Committee of Xijing Hospital (Approval Number: XJLL-KY-20262039). Written informed consent will be obtained from all participating patients or their legally authorized representatives prior to enrollment. The study will be conducted in strict accordance with the principles of the Declaration of Helsinki. All collected data will be de-identified, used solely for the purposes of this study, and stored in a secure, encrypted database.
10. Data Sharing Statement De-identified individual participant data, along with the study protocol and statistical analysis plan, will be made available to researchers who provide a methodologically sound proposal after the publication of the primary results. Data sharing requests will be subject to review and approval by the study steering committee.